667 results on '"Mehta, Puja K."'
Search Results
152. Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
153. Gender in cardiovascular medicine: chest pain and coronary artery disease
154. Coronary Microvascular Dysfunction Is Associated With Significant Plaque Burden and Diffuse Epicardial Atherosclerotic Disease
155. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers
156. Comparison of autonomic stress reactivity in young healthy versus aging subjects with heart disease
157. Adverse cardiovascular outcomes in women: blame the amygdala?
158. Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial
159. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
160. Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVD.
161. Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with Ranolazine
162. Prior myocardial infarction is associated with coronary endothelial dysfunction in women with signs and symptoms of ischemia and no obstructive coronary artery disease
163. Myocardial infarction with non-obstructive coronary arteries: a humbling diagnosis in 2018
164. CIRCULATING SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS PREDICT MORTALITY IN SUBJECTS WITHOUT OBSTRUCTIVE CORONARY ARTERY DISEASE
165. Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial
166. Role of Stress Cardiac Magnetic Resonance Imaging in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease
167. Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study
168. Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Women Versus Men
169. Quality and Equitable Health Care Gaps for Women
170. Cardiac autonomic function and vasomotor symptoms: too much break and not enough accelerator?
171. Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve
172. Phosphodiesterase type 5 inhibition may reduce diastolic function in women with ischemia but no obstructive coronary artery disease
173. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
174. Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial (Preprint)
175. Abstract 108: Impact of a Wireless "Wearable" Device to Measure Daily Activity in Patients With Coronary Microvascular Disease Treated With Late Na Channel Inhibition (ranolazine): a Substudy of the RWISE Clinical Trial
176. Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function
177. Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine
178. Higher Activation of the Rostromedial Prefrontal Cortex During Mental Stress Predicts Major Cardiovascular Disease Events in Individuals With Coronary Artery Disease
179. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
180. Cardio-Oncology : Principles, Prevention and Management
181. Hemodynamic Reactivity to Mental Stress in Patients With Coronary Artery Disease.
182. Gitelman syndrome presenting as Torsades de pointes
183. Diastolic dysfunction measured by cardiac magnetic resonance imaging in women with signs and symptoms of ischemia but no obstructive coronary artery disease
184. PREVALENCE OF SILENT MYOCARDIAL ISCHEMIA ON AMBULATORY MONITORING IN WOMEN WITH CORONARY MICROVASCULAR DYSFUNCTION
185. ABNORMAL CARDIAC SYMPATHETIC ACTIVITY DETECTED BY 123-I-META-IODOBENZYLGUANIDINE IMAGING IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY ARTERY DISEASE
186. CORONARY ENDOTHELIAL FUNCTION MEASURED BY ACETYLCHOLINE CORRELATES WITH COLD PRESSOR TESTING IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY ARTERY DISEASE
187. Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk
188. Interscan reproducibility of cardiovascular magnetic resonance myocardial perfusion reserve index in women with suspected coronary microvascular dysfunction and no obstructive coronary artery disease
189. Tissue characterization with native T1 mapping in suspected coronary microvascular dysfunction and no obstructive coronary artery disease: results from the NHLBI-sponsored WISE study
190. Subclinical systolic and diastolic dysfunction in women with signs and symptoms of ischemia but no obstructive coronary disease: novel insights using myocardial feature tracking in the NHLBI WISE study
191. Changes in left ventricular function and coronary blood flow velocity during isocapnic hypoxia: A cardiac magnetic resonance imaging study
192. Stroke in women: Where are we in 2015?
193. Cardiac Syndrome X
194. Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women
195. Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction
196. False‐positive stress testing: Does endothelial vascular dysfunction contribute to ST‐segment depression in women? A pilot study.
197. Mental stress peripheral vascular reactivity is elevated in women with coronary vascular dysfunction: Results from the NHLBI-sponsored Cardiac Autonomic Nervous System (CANS) study.
198. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
199. Abstract 10434: Non-Typical Angina and Mortality in Women With Obstructive Coronary Artery Disease: Results From the Women's Ischemia Syndrome Evaluation Study (WISE)
200. Do women with statin-related myalgias have low vitamin D levels?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.